Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Lucy Ghali"'
Autor:
David Madruga, Miguel M Garcia, Luca Martino, Haidar Hassan, Ghada Elayat, Lucy Ghali, Laura Ceballos
Publikováno v:
BMC Oral Health, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Periodontitis has a high prevalence and uncertain recurrence. Unlike the pro-inflammatory cytokine profile, little is known about the anti-inflammatory cytokine and antimicrobial peptide overview following treatment. The present s
Externí odkaz:
https://doaj.org/article/f2093c509eae47f4a85e2955991c9496
Autor:
Sandeep K Nadendla, Allon Hazan, Matt Ward, Lisa J Harper, Karwan Moutasim, Lucia S Bianchi, Mahmoud Naase, Lucy Ghali, Gareth J Thomas, David M Prowse, Michael P Philpott, Graham W Neill
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e20271 (2011)
The GLI (GLI1/GLI2) transcription factors have been implicated in the development and progression of prostate cancer although our understanding of how they actually contribute to the biology of these common tumours is limited. We observed that GLI re
Externí odkaz:
https://doaj.org/article/365ae24beb2e41ba800a69cc8387d6b0
Autor:
David Madruga, Miguel M Garcia, Luca Martino, Haidar Hassan, Ghada Elayat, Lucy Ghali, Laura Ceballos
Background. Periodontal disease represents a public health concern due to its high prevalence and uncertain recurrence after conventional treatment. Therapy outcome may be variable and given its multifactorial etiology, the precise mechanisms behind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17da5ca086c24196efd1fce0290ae217
https://doi.org/10.21203/rs.3.rs-2236013/v1
https://doi.org/10.21203/rs.3.rs-2236013/v1
Publikováno v:
Clinical Oncology and Research. :1-9
In this study three dimensional (3-D) in vitro models of normal breast and breast cancer tissues were developed to mimic closely the in vivo tissue microenvironment and therefore providing reliable models for in vitro studies as well as testing of no
Autor:
Lucy Ghali, Andreas Demosthenous, Nakul Parel, Nazanin Neshatvar, Richard Bayford, Nima Seifnaraghi, Yevhen Ivanenko, Sven Nordebo, Thomas W. Rademacher, Rui Damaso, Wu Yu, Ivan M. Roitt
Publikováno v:
IEEE transactions on bio-medical engineering. 69(1)
Objective: An imaging device to locate functionalised nanoparticles, whereby therapeutic agents are transported from the site of administration specifically to diseased tissues, remains a challenge for pharmaceutical research. Here, we show a new met
Colorectal cancer (CRC) is the fourth most common cancer in the world. Due to its asymptomatic nature, CRC is diagnosed at an advanced stage where the survival rate is in vitro. Four different types of coated-GNPs were synthesised GNPs-PEG, GNPs-anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93ea4774dbecc3febced056e8f0a6059
https://eprints.mdx.ac.uk/33759/1/d1na00318f_VoR.pdf
https://eprints.mdx.ac.uk/33759/1/d1na00318f_VoR.pdf
Publikováno v:
Nanoscale advances. 3(18)
Colorectal cancer (CRC) is the fourth most common cancer in the world. Due to its asymptomatic nature, CRC is diagnosed at an advanced stage where the survival rate is
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 9, p 2156 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 9
International Journal of Molecular Sciences
Volume 20
Issue 9
High-risk human papilloma virus (HPV) infection is directly associated with cervical cancer development. Arsenic trioxide (ATO), despite inducing apoptosis in HPV-infected cervical cancer cells in vitro, has been compromised by toxicity and poor phar
Publikováno v:
International Journal of Molecular Sciences; Volume 19; Issue 4; Pages: 1081
International Journal of Molecular Sciences, Vol 19, Iss 4, p 1081 (2018)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 19, Iss 4, p 1081 (2018)
International Journal of Molecular Sciences
Despite the success of arsenic trioxide (ATO) in treating haematological malignancies, its potential to treat solid tumours has not been fully exploited, owing to its dose-limiting toxicity and poor pharmacokinetics. In order to overcome this hurdle,
Publikováno v:
International review of neurobiology. 135
Advances in scientific research and targeted treatment regimes have improved survival rates for many cancers over the past few decades. However, for some types of leukemia, including acute lymphoblastic and acute myeloid leukemia, mortality rates hav